NYSE:ANTM - Anthem Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$263.17 -0.78 (-0.30 %)
(As of 08/20/2018 04:00 PM ET)
Previous Close$263.95
Today's Range$262.41 - $263.96
52-Week Range$179.40 - $268.04
Volume870,100 shs
Average Volume1.43 million shs
Market Capitalization$67.60 billion
P/E Ratio21.85
Dividend Yield1.13%
Beta0.89
Anthem logoAnthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Receive ANTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:ANTM
CUSIP94973V10
Phone800-331-1476

Debt

Debt-to-Equity Ratio0.61
Current Ratio1.52
Quick Ratio1.52

Price-To-Earnings

Trailing P/E Ratio21.85
Forward P/E Ratio17.00
P/E Growth1.42

Sales & Book Value

Annual Sales$90.04 billion
Price / Sales0.76
Cash Flow$16.2150 per share
Price / Cash16.23
Book Value$103.22 per share
Price / Book2.55

Profitability

EPS (Most Recent Fiscal Year)$12.04
Net Income$3.84 billion
Net Margins4.79%
Return on Equity13.28%
Return on Assets5.01%

Miscellaneous

Employees56,000
Outstanding Shares259,950,000
Market Cap$67.60 billion

Anthem (NYSE:ANTM) Frequently Asked Questions

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem announced a quarterly dividend on Wednesday, July 25th. Shareholders of record on Monday, September 10th will be given a dividend of $0.75 per share on Tuesday, September 25th. This represents a $3.00 annualized dividend and a yield of 1.14%. The ex-dividend date is Friday, September 7th. View Anthem's Dividend History.

How will Anthem's stock buyback program work?

Anthem declared that its board has approved a share buyback program on Friday, December 8th 2017, which permits the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company's leadership believes its stock is undervalued.

How were Anthem's earnings last quarter?

Anthem Inc (NYSE:ANTM) released its quarterly earnings results on Wednesday, July, 25th. The company reported $4.25 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $4.16 by $0.09. The company had revenue of $22.71 billion for the quarter, compared to analyst estimates of $22.66 billion. Anthem had a return on equity of 13.28% and a net margin of 4.79%. The business's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.37 earnings per share. View Anthem's Earnings History.

When is Anthem's next earnings date?

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Anthem.

What guidance has Anthem issued on next quarter's earnings?

Anthem updated its FY18 earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of > $15.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $15.40. The company issued revenue guidance of $91-92 billion, compared to the consensus revenue estimate of $91.19 billion.

What price target have analysts set for ANTM?

16 brokerages have issued twelve-month price targets for Anthem's stock. Their predictions range from $151.00 to $332.00. On average, they anticipate Anthem's stock price to reach $268.5833 in the next year. This suggests a possible upside of 2.1% from the stock's current price. View Analyst Price Targets for Anthem.

What is the consensus analysts' recommendation for Anthem?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Anthem.

What are Wall Street analysts saying about Anthem stock?

Here are some recent quotes from research analysts about Anthem stock:
  • 1. Cantor Fitzgerald analysts commented, "We rate Anthem (ANTM) Overweight and our price target remains at $275. Our price target includes the net present value of the potential pharmacy savings and our appropriately conservative outlook. Within our managed care coverage list, Anthem was the most-aggressive in pursuing the individual exchange market, as it tried to leverage its strong brand name (BlueCross). As risk pools did not develop as expected and the number of individuals signing up for insurance was below expectations, ANTM’s profitability suffered. The company is finally reversing this trend as evidenced by its 1H18 results." (7/25/2018)
  • 2. According to Zacks Investment Research, "Anthem's prudent acquisitions, improving net investment income, divestitures and ACO arrangements pave the way for long-term growth of the company. Its diverse product portfolio has also helped improving its underwriting results. Following the acquisition of America's 1st Choice and HealthSun Anthem, Anthem emerged as the third largest Medicare Advantage plan in the fast-growing Florida market. The company’s solid medical membership should boost its revenues. Its strong capital position backs effective capital deployment via share buybacks and regular dividends. The company’s shares have witnessed its 2018 and 2019 earnings estimates move upward. However, reduction in individual membership from exits in the ACA-compliant marketplace dragged the top line. Shares of the company have underperformed the growth of its industry in the past year. Loss incurred on public exchange business and rising debt continue to bother." (7/3/2018)

Who are some of Anthem's key competitors?

Who are Anthem's key executives?

Anthem's management team includes the folowing people:
  • Ms. Gail Koziara Boudreaux, Pres, CEO & Director (Age 57)
  • Mr. John Edward Gallina, Exec. VP & CFO (Age 58)
  • Ms. Gloria Marie McCarthy, Exec. VP and Chief Admin. & Transformation Officer (Age 65)
  • Mr. Peter David Haytaian, Exec. VP & Pres of Commercial and Specialty Bus. Division (Age 48)
  • Mr. Ronald William Penczek, Sr. VP & Chief Accounting Officer (Age 53)

Has Anthem been receiving favorable news coverage?

News articles about ANTM stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Anthem earned a news and rumor sentiment score of 0.23 on Accern's scale. They also assigned media stories about the company an impact score of 47.05 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Anthem.

Who are Anthem's major shareholders?

Anthem's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (1.88%), Dimensional Fund Advisors LP (1.14%), Boston Partners (1.12%), OppenheimerFunds Inc. (0.93%), Sanders Capital LLC (0.74%) and Artisan Partners Limited Partnership (0.69%). Company insiders that own Anthem stock include Brian T Griffin, Craig E Samitt, Gloria M Mccarthy, John E Gallina, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Institutional Ownership Trends for Anthem.

Which major investors are selling Anthem stock?

ANTM stock was sold by a variety of institutional investors in the last quarter, including Vulcan Value Partners LLC, Renaissance Technologies LLC, Canada Pension Plan Investment Board, LSV Asset Management, Bank of Montreal Can, Janus Henderson Group PLC, NN Investment Partners Holdings N.V. and Polaris Capital Management LLC. Company insiders that have sold Anthem company stock in the last year include Brian T Griffin, Craig E Samitt, Gloria M Mccarthy, John E Gallina, Joseph Swedish, Julie A Hill, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Insider Buying and Selling for Anthem.

Which major investors are buying Anthem stock?

ANTM stock was acquired by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Orbimed Advisors LLC, Artisan Partners Limited Partnership, Bessemer Group Inc., Sei Investments Co., Natixis, Price Wealth Management Inc. and Unigestion Holding SA. View Insider Buying and Selling for Anthem.

How do I buy shares of Anthem?

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anthem's stock price today?

One share of ANTM stock can currently be purchased for approximately $263.17.

How big of a company is Anthem?

Anthem has a market capitalization of $67.60 billion and generates $90.04 billion in revenue each year. The company earns $3.84 billion in net income (profit) each year or $12.04 on an earnings per share basis. Anthem employs 56,000 workers across the globe.

How can I contact Anthem?

Anthem's mailing address is 120 MONUMENT CIRCLE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]


MarketBeat Community Rating for Anthem (NYSE ANTM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  563 (Vote Outperform)
Underperform Votes:  591 (Vote Underperform)
Total Votes:  1,154
MarketBeat's community ratings are surveys of what our community members think about Anthem and other stocks. Vote "Outperform" if you believe ANTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel